Volume 19 Part 1 Article 107: Optimization of Ganoderma Lucidum Cultivation and Comparison of Bioactive Compounds in Fruiting Bodies, Spores and Mycelium

Volume 19 Part 1 Article 107
Year 2016
Title: Optimization of Ganoderma Lucidum Cultivation and Comparison of Bioactive Compounds in Fruiting Bodies, Spores and Mycelium
Author: Margarita Pérez-Clavijo, Maria Luisa Tello-Martín, Irene Roncero-Ramos, Vanessa Grifoll-García

Abstract:
Ganoderma lucidum has been traditionally used in Chinese medicine for the prevention and treatment of various diseases. The major bioactive components extracted from their fruiting body, mycelium or spores include polysaccharides and triterpenoids. These compounds are of great interest for their pharmacological effects, such as immunomodulation, anti-cancer or anti-diabetic activity. Traditionally, bioactive components have been extracted from fruiting bodies. Therefore, to obtain a satisfactory yield of mushrooms, it is essential to optimize growing conditions and substrate formulation. Due to the long time required for fruiting body growing, research with new alternatives such as using liquid medium culture for the production of mycelia biomass and bioactive compounds is been conducted.

Please login to download the PDF for this proceeding.